'Advocacy groups are the connectors': Experiences and contributions of rare disease patient organization leaders in advanced neurotherapeutics.

44 This study reaffirms a positive trend in patient research involvement observed throughout Western countries since the turn of the 21st century. 45 While reinforcing previous literature on RDPO community and advocacy roles, it principally aligns with prior studies that have projected exponential growth in the influence of research‐e

also in 11,005 other papers